The conventional wisdom is that Americans pay far more for prescription drugs than patients in other developed countries. This belief has fueled bipartisan calls for heavy-handed measures such as price controls, punitive taxes, and even nationalization of drug manufacturers.
Lawmakers feel pressure from two directions. Patients experience drug prices more directly than other medical bills because of how insurance is structured. At the same time, healthcare costs are the single largest category of spending at the federal and state levels, which puts enormous strain on budgets.
But what if this conventional wisdom is wrong? A new study challenges what we thought we knew about drug prices in America and flips the narrative on its head.
Do you want access to more of Newt’s commentary? Become a member of Newt’s Inner Circle to get even more involved in our nation’s happenings. If you join today, you’ll receive a free autographed copy of one of Newt’s best sellers.
- The Jeffersonian Political Future
Republicans should develop a broad embracing platform which will be supported by 75 percent to 80 percent of the American people. - The Hospital-Insurance Company Rip Off System
There has been a long struggle to enable Americans to know what they are really paying for in healthcare — and what their options are in quality and price of service. - Mamdani’s Anti-American Fantasy Reflects Far Left’s Reliance on Alternative Facts
If the radical left is forced to stick with the record and the facts, its complaints fall apart. - The Empire of Liberty vs the Dictatorship of Hate
Watching the parallel television coverage of the American celebration of our 250th anniversary and the funeral of Ayatollah Ali Khamenei gave me a deep sense of contrast. - Bite of Capital Gains Taxes Can Be Eased, as Greenspan Foresaw, by Adjusting for Inflation
Why, asked ‘the Maestro,’ should anyone have to pay taxes on fake appreciation driven by a declining currency rather than a real gain?